Mineralys Therapeutics, Inc.
Public company- Headquarters
- RADNOR, Pennsylvania
- Ticker
- MLYS
- CIK
- 0001933414
WARN notices since 2024
0
None on record
Workers affected since 2024
0
Across 0 notices
Executive changes, last 12 months
4
3 appointments, 1 departure
Last event
Nov 4, 2026
Executive departureDirector departs: Derek DiRocco, Ph.D.
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| DirectorDerek DiRocco, Ph.D. | Nov 4, 2026 | Departed |
| Class I directorKristine Peterson | Oct 19, 2026 | Appointed |
| Class II directorLonnel Coats | Oct 19, 2026 | Appointed |
| CMOJames J. Ferguson III, M.D. | Aug 11, 2026 | Appointed |
Related companies
Same industry and state, with recent events.
- MADRIGAL PHARMACEUTICALS, INC.
Class II director appointed: John C. Reed, M.D., Ph.D.
- BRISTOL MYERS SQUIBB CO
WARN notice: Princeton, NJ
- JOHNSON & JOHNSON
WARN notice: New Brunswick, NJ
- Merck & Co., Inc.
WARN notice: Rahway, NJ
No events of this type on record.
Show all eventsLast verified Nov 8, 2026